CVRX
CVRx, Inc.
CVRX lost money over the past year, so it has no meaningful PE right now.
CVRX Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Under pressure | |
| Weak | |
| Unavailable |
CVRX's revenue is currently stable, but its profitability and cash flow are under pressure. There isn't enough data to rate its balance sheet.
CVRX PE Valuation
CVRX has no meaningful PE right now: it lost money over the past year.
CVRX Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses steady | |
| Stable | |
| Stable | |
| Limited | |
| Moderate |
Analysts expect CVRX's earnings, revenue and profitability to hold roughly steady.
CVRX Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$2.00 | -$0.02 |
| Q2 2026 | -$1.97 | +$0.09 |
| Q1 2026 | -$2.01 | +$0.13 |
| Q4 2025 | -$2.04 | +$0.61 |
| Q3 2025 | -$1.98 | +$0.73 |
| Q2 2025 | -$2.06 | +$0.51 |
| Q1 2025 | -$2.14 | +$0.34 |
| Q4 2024 | -$2.65 | -$0.66 |
CVRX is still losing money, but less than at its worst: $2.00 per share over the past year, against $2.71 at its worst in late 2024.
CVRX Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $13.8M | -5.8% |
| Q2 2026 | $15.7M | +16% |
| Q1 2026 | $14.8M | +20% |
| Q4 2025 | $16M | +4.4% |
| Q3 2025 | $14.7M | +9.8% |
| Q2 2025 | $13.6M | +15% |
| Q1 2025 | $12.3M | +15% |
| Q4 2024 | $15.3M | +36% |
CVRX's revenue is growing: $14M last quarter, down 5.8% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -94% | -11 points |
| Q2 2026 | -83% | +23 points |
| Q1 2026 | -82% | +27 points |
| Q4 2025 | -70% | -2.8 points |
| Q3 2025 | -84% | +14 points |
| Q2 2025 | -106% | +13 points |
| Q1 2025 | -109% | +98 points |
| Q4 2024 | -67% | +19 points |
CVRX's operating margin was −94% last quarter, down 11 points from the same quarter a year ago.
CVRX Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$11M | -$991K |
| Q2 2026 | -$8.9M | -$899K |
| Q1 2026 | -$12.3M | +$595K |
| Q4 2025 | -$9.8M | -$1.8M |
| Q3 2025 | -$10M | +$443K |
| Q2 2025 | -$8M | +$2.1M |
| Q1 2025 | -$12.9M | -$1.1M |
| Q4 2024 | -$8.1M | -$52K |
CVRX has burned cash in almost every quarter: −$42M over the past year, against −$39M the year before.
CVRX Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +2.8% | +731K shares |
| 1 year | +4.1% | +1.1M shares |
| 3 years | +31% | +6.4M shares |
| 5 years | +7343% | +26.9M shares |
CVRX has 27M diluted shares, up 4.1% from a year ago.
| Quarter | Spent |
|---|---|
| Q1 2021 | — |
| Q4 2020 | — |
| Q3 2020 | — |
| Q2 2020 | — |
| Q1 2020 | — |
CVRX Net Leverage
CVRX's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
CVRX Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 26.1 | Oversold |
| Stochastic | 1.7 | Oversold |
CVRX's weekly RSI is 26 (oversold) and its Stochastic is 2 (oversold).
CVRX PE vs Healthcare Sector
CVRX has no meaningful PE right now: it lost money over the past year.
CVRX Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1.43 | 56% below |
| 20 week MA | $2.88 | 78% below |
| 50 week MA | $5.38 | 88% below |
| 100 week MA | $7.50 | 92% below |
| 200 week MA | $11.1 | 94% below |
CVRX is in a downtrend: it's below all five of its weekly moving averages, and 94% below its 200-week average.
CVRX Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $25.5 | $12.2 | -52% |
| 2022 | $12.2 | $16.7 | +37% |
| 2023 | $16.7 | $31.4 | +88% |
| 2024 | $31.4 | $13.2 | -58% |
| 2025 | $13.2 | $7.42 | -44% |
| 2026 YTD | $7.42 | $0.63 | -92% |
CVRX has finished lower in three of the last five years. It's down 92% so far in 2026.